Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald M Cohen

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cell Death and Differentiation|September 7, 2018
BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X<sub>L</sub>Georgia Greaves, Mateus Milani, Michael Butterworth, et al.
British Journal of Haematology|October 10, 2007
TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2Alessandro Natoni, Marion MacFarlane, Satoshi Inoue, et al.
Haematologica|November 24, 2018
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignanciesAoula Al-Zebeeby, Meike Vogler, Mateus Milani, et al.
Hepatology (Baltimore, Md.)|August 21, 2007
Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liverXandra Volkmann, Ute Fischer, Matthias J Bahr, et al.
Haematologica|April 10, 2010
Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cellsMaria Baou, Susan L Kohlhaas, Michael Butterworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2007
Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosisBerna S Sayan, A Emre Sayan, Ai Li Yang, et al.
Blood|May 13, 2011
BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activationMeike Vogler, Hassan A Hamali, Xiao-Ming Sun, et al.
Cell Death & Disease|December 6, 2019
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neckRachel J Carter, Mateus Milani, Michael Butterworth, et al.
Oncotarget|May 8, 2018
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growthPatrick Casara, James Davidson, Audrey Claperon, et al.
Cell Death and Differentiation|January 25, 2018
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cell Death and Differentiation|September 7, 2018
BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X<sub>L</sub>Georgia Greaves, Mateus Milani, Michael Butterworth, et al.
British Journal of Haematology|October 10, 2007
TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2Alessandro Natoni, Marion MacFarlane, Satoshi Inoue, et al.
Haematologica|November 24, 2018
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignanciesAoula Al-Zebeeby, Meike Vogler, Mateus Milani, et al.
Hepatology (Baltimore, Md.)|August 21, 2007
Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liverXandra Volkmann, Ute Fischer, Matthias J Bahr, et al.
Haematologica|April 10, 2010
Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cellsMaria Baou, Susan L Kohlhaas, Michael Butterworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2007
Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosisBerna S Sayan, A Emre Sayan, Ai Li Yang, et al.
Blood|May 13, 2011
BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activationMeike Vogler, Hassan A Hamali, Xiao-Ming Sun, et al.
Cell Death & Disease|December 6, 2019
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neckRachel J Carter, Mateus Milani, Michael Butterworth, et al.
Oncotarget|May 8, 2018
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growthPatrick Casara, James Davidson, Audrey Claperon, et al.
Cell Death and Differentiation|January 25, 2018
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, et al.
Pageof 5